Dutasteride Tablet 0.5 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or older adults. Since there are no data on administration of this medicine to patients with hepatic impairment, the recommended dose in these patients has not been established.

This medication should never be used or touched by women, especially those who are pregnant or may become pregnant. The drug can be absorbed through the skin and has a risk of affecting the development of the male fetus's genitalia. Care should be taken to avoid children touching pieces that are broken or fractured. Women and children under 18 years should not take this medication, nor should anyone allergic to this drug or similar compounds. Adult men planning to conceive should consult a doctor as this drug may affect fertility. Patients with severe urinary obstruction or significant reduction in urinary flow should use caution when administering this drug and should closely monitor for urinary retention symptoms. Patients with liver dysfunction should also be cautious when taking this medication. Close monitoring is required when taken with potent CYP3A4 inhibitors as this may increase the blood concentration of the drug. This medication is primarily used for the treatment of benign prostatic hyperplasia or male pattern hair loss, and side effects such as sexual dysfunction (erectile dysfunction, decreased libido, ejaculation disorders), gynecomastia, headache, and gastrointestinal discomfort may occur during treatment. These side effects may persist even after discontinuing use. Additionally, this drug lowers PSA levels, which is important for prostate cancer risk assessment, so caution is needed when interpreting PSA tests. Regular prostate cancer testing is recommended while taking this drug. This medication is prohibited from being donated for at least 6 months after use to prevent transmission to pregnant women during blood transfusions. There is no specific antidote for overdose, and appropriate treatment is necessary according to symptoms. This drug should be kept out of reach of children and stored in its original container for safety. It is known to have no effect on the ability to drive or operate machinery. Patients with heart failure should be cautious when taking this medication in combination with alpha-blockers as it may increase the risk of heart failure. While this drug has minimal interactions with other medications, caution should be exercised when taken with CYP3A4 inhibitors, and no significant clinical issues have been reported when used with common antihypertensives, anticoagulants, or heart medications.

• erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly sealed container to prevent air exposure, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets per box [10 tablets/PTP x 3]